Multicenter phase II trial of palbociclib, a selective cyclin dependent kinase (CDK) 4/6 inhibitor, and cetuximab in platinum-resistant HPV unrelated (-) recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC).

Author:

Adkins Douglas1,Oppelt Peter John2,Ley Jessica C.3,Trinkaus Kathryn4,Neupane Prakash C.5,Sacco Assuntina Gesualda6,Palka Kevin A7,Worden Francis P.8,Grilley-Olson Juneko E.9,Maggiore Ronald John10,Steuer Conor Ernst11,Saba Nabil F.12

Affiliation:

1. Washington University School of Medicine in St. Louis and Siteman Cancer Center, St. Louis, MO;

2. University Hospital Case Medical Center, Cleveland, OH;

3. Washington University School of Medicine, St. Louis, MO;

4. Washington University School of Medicine in St. Louis Siteman Cancer Center, St. Louis, MO;

5. University of Kansas Medical Center, Westwood, KS;

6. University of California San Diego Moores Cancer Center, La Jolla, CA;

7. Saint Louis University School of Medicine, Saint Louis, MO;

8. University of Michigan Comprehensive Cancer Center, Ann Arbor, MI;

9. University of North Carolina at Chapel Hill, Chapel Hill, NC;

10. University of Rochester, Rochester, NY;

11. Winship Cancer Institute of Emory University, Atlanta, GA;

12. Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3